Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Photochem Photobiol B ; 205: 111824, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32126496

ABSTRACT

Excessive exposure to UVB radiation can lead to oxidative and inflammatory damage that compromises the cutaneous integrity. The application on the skin of photochemoprotective products is considered a relevant approach for the prevention of oxidative damage. In this study the in vitro and in vivo photochemoprotective effects of antioxidant plant materials obtained from the leaves of Nectandra cuspidata Nees following UVB irradiation were evaluated. The cytoprotective effect, reactive oxygen species (ROS) production and lipid peroxidation (LPO) were assessed in L-929 fibroblasts treated with the ethyl acetate fraction (EAF) or isolated compounds (epicatechin, isovitexin and vitexin) before or after irradiation with UVB (500 mJ/cm2). EAF substantially reduced the dead of cells and inhibited the UVB-induced ROS production and LPO in both treatments, compared with the irradiated untreated fibroblasts, presenting effects similar or better than pure compounds. The in vivo photochemoprotective effects of a topical emulsion containing 1% EAF (F2) were evaluated in hairless mice exposed to UVB. F2 improved all evaluated parameters in the skin of animals, inhibited ROS production, increased antioxidant defenses by decreasing reduced glutathione (GSH) and catalase depletion, reduced the activities of metalloproteinases (MMP-2 and MMP-9) and myeloperoxidase, decreased epidermal thickness and skin edema, and inhibited the appearance of sunburn cells as well as the recruitment of neutrophils and mast cell inflammatory infiltrates. These findings show that EAF presents high photochemoprotective effects, and that a topical formulation containing it may have potential for skin care.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Fibroblasts/drug effects , Lauraceae , Plant Extracts/pharmacology , Polyphenols/pharmacology , Radiation-Protective Agents/pharmacology , Skin/drug effects , Ultraviolet Rays/adverse effects , Animals , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Female , Fibroblasts/radiation effects , Lipid Peroxidation/drug effects , Male , Mice, Hairless , Plant Leaves , Reactive Oxygen Species/metabolism , Skin/metabolism , Skin/pathology , Skin/radiation effects
2.
Biol Pharm Bull ; 29(11): 2241-5, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17077521

ABSTRACT

The present study evaluated the effect of the crude extract of the leaves of Nectandra falcifolia (NEES) Castiglioni and its fractions in different experimental models of inflammation (paw edema, pleurisy, and ear edema). Carrageenan-induced edema of the paw and pleurisy were evaluated in Wistar rats (180-220 g), which were treated with different doses of the total extract (250, 500 mg.kg-1). Edema of the ear, induced by croton oil, and determination of myeloperoxidase activity were evaluated in Swiss mice (25-35 g). In this experiment, the crude extract of Nectandra falcifolia (Nf) (1.25, 2.5, 5.0, 7.5 mg) and the hexane, chloroform, ethyl-acetate and hydromethanol fractions (5.0 mg) were applied topically, immediately after application of the oil. The crude extract of Nf (500 mg.kg-1) significantly reduced edema of the paw compared to the control group. Similarly, at doses of 250 and 500 mg.kg-1 it significantly reduced the volume of pleural inflammatory exudate compared to the control animals. However, it did not change the number of migrated cells. At doses of 2.5, 5.0 and 7.5 mg, the crude extract significantly inhibited edema of the ear and the influx of neutrophils. The fractions from Nectandra falcifolia (hexane, chloroform, ethyl acetate and hydromethanol) also inhibited edema of the ear. Taken together, the results demonstrated that the crude extract and its fractions administered to animals orally or topically showed an anti-inflammatory effect.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Lauraceae/chemistry , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Administration, Oral , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Carrageenan/administration & dosage , Carrageenan/toxicity , Croton Oil/administration & dosage , Croton Oil/toxicity , Drug Evaluation, Preclinical/methods , Ear/pathology , Edema/chemically induced , Edema/metabolism , Edema/prevention & control , Hindlimb/drug effects , Hindlimb/pathology , Indomethacin/pharmacology , Indomethacin/therapeutic use , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/prevention & control , Injections, Intradermal , Male , Nitric Oxide/metabolism , Peroxidase/metabolism , Phytotherapy/methods , Plant Extracts/chemistry , Plant Extracts/pharmacology , Pleurisy/chemically induced , Pleurisy/metabolism , Pleurisy/prevention & control , Rats , Rats, Wistar , Solvents/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...